End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 18 | JonesTrading Starts Rezolute With Buy Rating, $10 Price Target | MT |
Mar. 06 | Rezolute, Inc. Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia | CI |
- Stock Market
- Equities
- RZLT Stock
- Stock
- News AntriaBio Inc